US$ 26.18
glp 1 agonists drug class Table from Glucagon-Like Peptide-1 (GLP-1) Receptor Review How should we approach patients
Description
The good news is, with the right strategy, you can hold on to most of your muscle while losing fat on GLP-1 therapy
The primary outcome was the incremental cost-effectiveness ratio (ICER), defined as cost per QALY gained, with the willingness-to-pay threshold set at AU$28,000 per QALY [15]

Type 3 cytokines IL-17A and IL-22 drive TGF--dependent liver fibrosis

28 , 849857 (1985) Sciabola, S

Tirzepatide and Blood Pressure Reduction: Stratified Analyses of the SURMOUNT-1 Randomised Controlled Trial
